.png?width=1920&height=1080&name=MicrosoftTeams-image%20(12).png)
Overcome the challenges of PMS2 variant calling with Devyser LynchFAP – our new NGS solution
Devyser LynchFAP is the latest addition to Devyser’s expanding hereditary cancer screening...
News | September 06, 2023
Devyser and Thermo Fisher Scientific expand the collaboration for post-transplant NGS products by adding BrazilNews | July 17, 2023
Devyser’s NGS products for monitoring of kidney and stem cell transplant patients receive IVDR approvalsNews | June 29, 2023
Devyser launches two new genetic testing solutions for hereditary cancer
Devyser launches two new genetic testing solutions for hereditary cancer
Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA...
Simplify your lab workflow with single-tube NGS library preparation method
As a lab manager, you know the importance of streamlining workflows to maximize productivity and...
NGS identification of both male and female cancer risks
Do you know a man who has participated at least once in “Movember”? Every year, thousands of men...